Could a pill boost performance in extreme cold and thin air?
NCT ID NCT06129825
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study tests whether a drug can help red blood cells work better in low-oxygen (hypoxia) and cold (hypothermia) conditions, which are common in high-altitude or military environments. Researchers will measure how the drug affects red blood cell energy and antioxidant defenses in 50 healthy adults. The goal is to understand if the drug can improve the body's ability to adapt to extreme conditions, not to cure or treat a disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPOTHERMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Maryland Baltimore
Baltimore, Maryland, 21201, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new MRI scan reveal hidden tumor weaknesses?
- AI crystal ball for hospital wards: can software forecast oxygen drops 24 hours early?
- Thin air, thicker blood? hypoxia training may supercharge red blood cell production โ at a cost
- Oxygen test during pregnancy may predict brain development in Heart-Defect babies
- Hidden toll of routine ICU procedure revealed: suctioning may spike pain and stress
- Chilled saline infused directly into brain during stroke treatment may limit damage